Group 6 Copy 80
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Round Goby assault on American rivers: How fast, how far, how complete?

    After conquering the Great Lakes, what will the invasive Round Goby do to fish in our streams? Four years...

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    Short-Term Innovative Research (STIR): Predoctoral Grant Competition

    Writing grants is the number one skill required for a successful independent scientist. This project provides...

    Backer Badge Funded

    A biology project funded by 47 people